The Net Margin of Hikma Pharmaceuticals PLC (HIK.L) is 11.38%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 11.38% |
| 2023-12-31 | 6.61% |
| 2022-12-31 | 7.47% |
| 2021-12-31 | 16.49% |
| 2020-12-31 | 18.41% |
| 2019-12-31 | 22.06% |
| 2018-12-31 | 13.58% |
| 2017-12-31 | -43.54% |
| 2016-12-31 | 7.95% |
| 2015-12-31 | 17.50% |